An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)

Expanded Access Program of Ponatinib

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Study of Adagloxad Simolenin (OBI-822) and OBI-821 Versus Placebo Treatment for High Risk Early Stage Triple Negative Breast Cancer Patients (TNBC) Following Neoadjuvant or Adjuvant Chemotherapy.

Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC